Impaired verbal fluency under topiramate - evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy

European Journal of Neurology

Volumn 20, Issue 1, 2013, Pages 130-137

  Witt, J A ^a   Elger, C E ^a   Helmstaedter, C ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cognition; Cognitive side effects; Drug load; Epilepsy; Executive function; Neuropsychology; Topiramate; Verbal fluency

Indexed keywords

BROMIDE; CARBAMAZEPINE; CLOBAZAM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOSE RESPONSE; EDUCATIONAL STATUS; EPILEPSY; FEMALE; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TASK PERFORMANCE; VERBAL FLUENCY IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTICONVULSANTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SPEECH DISORDERS; YOUNG ADULT;

EID: 84871645069     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03814.x     Document Type: Article

References (32)

1. Lyseng-Williamson KA, Yang LP. Topiramate: a review of its use in the treatment of epilepsy. Drugs 2007; 67: 2231-2256.
2. Gesellschaft für Datenverarbeitung mbH. GKV-Daten 12-Monatswert 06/2011. Karlsfeld: Gesellschaft für Datenverarbeitung mbH, 2011.
3. Blum D, Meador K, Biton V, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006; 67: 400-406.
4. de Araujo Filho GM, Pascalicchio TF, Lin K, Sousa PS, Yacubian EM. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate. Epilepsy Behav 2006; 8: 606-609.
5. Fritz N, Glogau S, Hoffmann J, Rademacher M, Elger CE, Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005; 6: 373-381.
6. Gomer B, Wagner K, Frings L, et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav 2007; 10: 486-494.
7. Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 2003; 54: 171-178.
8. Kockelmann E, Elger CE, Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004; 5: 716-721.
9. Lee HW, Jung DK, Suh CK, Kwon SH, Park SP. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up. Epilepsy Behav 2006; 8: 736-741.
10. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003; 60: 1483-1488.
11. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999; 52: 321-327.
12. Meador KJ, Loring DW, Vahle VJ, et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005; 64: 2108-2114.
13. Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005; 64: 792-798.
14. Silberstein S, Diener HC, Lipton R, et al. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache 2008; 48: 1087-1095.
15. Romigi A, Cervellino A, Marciani MG, et al. Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. Eur J Neurol 2008; 15: 190-195.
16. Burton LA, Harden C. Effect of topiramate on attention. Epilepsy Res 1997; 27: 29-32.
17. Huppertz HJ, Quiske A, Schulze-Bonhage A. Cognitive impairments due to add-on therapy with topiramate. Nervenarzt 2001; 72: 275-280.
18. Thompson PJ, Baxendale SA, Duncan JS, Sander JW. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000; 69: 636-641.
19. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003; 44: 339-347.
20. Jung KY, Cho JW, Joo EY, et al. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials. Clin Neurophysiol 2010; 121: 1494-1501.
21. Jansen JF, Aldenkamp AP, Marian Majoie HJ, et al. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav 2006; 9: 181-185.
22. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000; 41: 1167-1178.
23. Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J. Topiramate dose effects on cognition: a randomized double-blind study. Neurology 2011; 76: 131-137.
24. Horn W. Leistungs-Prüf-System (LPS). Bern: Verlag Hans Huber, 1983.
25. Henry JD, Crawford JR. A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 2004; 18: 284-295.
26. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997; 35: 241-256.
27. Diaz RA, Sancho J, Serratosa J. Antiepileptic drug interactions. Neurologist 2008; 14: S55-S65.
28. Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 2004; 3: 663-672.
29. Kwan P, Brodie M. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001; 357: 216-222.
30. Aldenkamp AP. Cognitive and behavioural assessment in clinical trials: when should they be done? Epilepsy Res 2001; 45: 155-157.
31. Meador KJ. Cognitive effects of levetiracetam versus topiramate. Epilepsy Curr 2008; 8: 64-65.
32. Weiss EM, Ragland JD, Brensinger CM, Bilker WB, Deisenhammer EA, Delazer M. Sex differences in clustering and switching in verbal fluency tasks. J Int Neuropsychol Soc 2006; 12: 502-509.